Australia markets closed

Clarus Therapeutics Holdings, Inc. (CRXT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.4300+0.0202 (+4.93%)
At close: 04:00PM EDT
0.4250 -0.00 (-1.16%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
13,957
13,957
6,369
Cost of revenue
2,720
2,720
8,687
Gross profit
11,237
11,237
-2,318
Operating expenses
Research development
3,630
3,630
2,398
Selling general and administrative
47,339
47,339
42,461
Total operating expenses
50,969
50,969
44,859
Operating income or loss
-39,732
-39,732
-47,177
Interest expense
15,895
15,895
15,394
Total other income/expenses net
15,008
15,008
66,891
Income before tax
-40,617
-40,617
4,345
Income tax expense
0
0
0
Income from continuing operations
-40,617
-40,617
4,345
Net income
-40,617
-40,617
4,345
Net income available to common shareholders
-40,205
-40,205
-10,337
Basic EPS
-
-5.72
-0.48
Diluted EPS
-
-5.72
-3.22
Basic average shares
-
7,028
21,726
Diluted average shares
-
7,028
21,726
EBITDA
-
-24,697
19,757